The recent identification of driver oncogenes, such as EGFR [1,2,3], ALK [4,5,6,7], ROS1 [8], and BRAF [9,10] has already been successfully translated into clinical practice for individuals with lung cancer. Here, EGFR is linked to lung carcinoma.